Trump’s new coronavirus vaccine czar owns $10 million in stock options in company developing vaccine
The former pharmaceutical executive named by President Donald Trump to lead a federal coronavirus vaccine development project owns more than $10 million in stock options in a company that has received federal funding to develop such a vaccine. Trump last week announced that Moncef Slaoui, the former head of vaccine development at the pharmaceutical giant GlaxoSmithKline, would be the chief… Read more…
